US FDA plant observations at Cipla cause 6-month delay in product launches: CEO
The biggest product under manufacture in the Pithampur facility is Advair which has a market size of $700 million
Source: moneycontrol.com
Ipla Q2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ipla Q2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ipla Q2 Today - Breaking & Trending Today
Cipla Q4 Preview: Another quarter of steady growth, margins to improve
Cipla's strong growth in its chronic therapies and over-the-counter consumer segment is likely to offset the weakness in sales of acute drugs in the domestic market
Source: moneycontrol.com